Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A G Harris

Showing results (131-140 of 145) with videos related to

Pageof 15
Sort By:
The American Journal of Gastroenterology|August 1, 1995
Right corpus cavernosum metastasis of a left colonic adenocarcinomaP Hastier, D Bianchi, A G Harris, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 24, 2017
Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trialJ P Bilezikian, G Hattersley, L A Fitzpatrick, et al.
The Clinical Investigator|July 1, 1992
Gallstones in acromegalic patients undergoing different treatment regimensK Schmidt, M Leuschner, A G Harris, et al.
Clinical Endocrinology|April 21, 1999
Decreased regional blood flow in patients with acromegalyP Chanson, J L Megnien, M del Pino, et al.
Digestive Diseases and Sciences|May 20, 1998
Solitary hepatic infantile myofibromatosis in a female adolescentP Hastier, F X Caroli-Bosc, A G Harris, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Effects of biliary lithogenesis in acromegalic patients with long-term octreotide (SMS 201-995) treatment]L E Buscail, C Puel-Bousquet, A G Harris, et al.
Digestive Diseases and Sciences|March 1, 1996
Pyoderma gangrenosum with hepatopancreatic manifestations in a patient with rheumatoid arthritisP Hastier, F X Caroli-Bosc, H R Bartel, et al.
Bone|October 26, 2018
Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trialP D Miller, G Hattersley, E Lau, et al.
International Journal of Women'S Dermatology|May 12, 2017
The reliability and validity of outcome measures for atopic dermatitis in patients with pigmented skin: A grey areaC Y Zhao, A Wijayanti, M C Doria, et al.
Digestive Diseases and Sciences|July 1, 1995
Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development PanelA G Harris, T M O'Dorisio, E A Woltering, et al.
Pageof 15

Showing results (131-140 of 145) with videos related to

Sort By:
Pageof 15
The American Journal of Gastroenterology|August 1, 1995
Right corpus cavernosum metastasis of a left colonic adenocarcinomaP Hastier, D Bianchi, A G Harris, et al.
Osteoporosis International : a Journal Established As Result of Cooperation Between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA|November 24, 2017
Abaloparatide-SC improves trabecular microarchitecture as assessed by trabecular bone score (TBS): a 24-week randomized clinical trialJ P Bilezikian, G Hattersley, L A Fitzpatrick, et al.
The Clinical Investigator|July 1, 1992
Gallstones in acromegalic patients undergoing different treatment regimensK Schmidt, M Leuschner, A G Harris, et al.
Clinical Endocrinology|April 21, 1999
Decreased regional blood flow in patients with acromegalyP Chanson, J L Megnien, M del Pino, et al.
Digestive Diseases and Sciences|May 20, 1998
Solitary hepatic infantile myofibromatosis in a female adolescentP Hastier, F X Caroli-Bosc, A G Harris, et al.
Gastroenterologie Clinique Et Biologique|January 1, 1991
[Effects of biliary lithogenesis in acromegalic patients with long-term octreotide (SMS 201-995) treatment]L E Buscail, C Puel-Bousquet, A G Harris, et al.
Digestive Diseases and Sciences|March 1, 1996
Pyoderma gangrenosum with hepatopancreatic manifestations in a patient with rheumatoid arthritisP Hastier, F X Caroli-Bosc, H R Bartel, et al.
Bone|October 26, 2018
Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trialP D Miller, G Hattersley, E Lau, et al.
International Journal of Women'S Dermatology|May 12, 2017
The reliability and validity of outcome measures for atopic dermatitis in patients with pigmented skin: A grey areaC Y Zhao, A Wijayanti, M C Doria, et al.
Digestive Diseases and Sciences|July 1, 1995
Consensus statement: octreotide dose titration in secretory diarrhea. Diarrhea Management Consensus Development PanelA G Harris, T M O'Dorisio, E A Woltering, et al.
Pageof 15